These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36007677)

  • 1. Nimbolide enhances the antitumor effect of docetaxel via abrogation of the NF-κB signaling pathway in prostate cancer preclinical models.
    Zhang J; Jung YY; Mohan CD; Deivasigamani A; Chinnathambi A; Alharbi SA; Rangappa KS; Hui KM; Sethi G; Ahn KS
    Biochim Biophys Acta Mol Cell Res; 2022 Dec; 1869(12):119344. PubMed ID: 36007677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization.
    Li Y; Zhang B; Xiang L; Xia S; Kucuk O; Deng X; Boise LH; Dong JT
    Theranostics; 2020; 10(17):7656-7670. PubMed ID: 32685011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer cells hyper-activate CXCR6 signaling by cleaving CXCL16 to overcome effect of docetaxel.
    Kapur N; Mir H; Sonpavde GP; Jain S; Bae S; Lillard JW; Singh S
    Cancer Lett; 2019 Jul; 454():1-13. PubMed ID: 30974114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATM/NEMO signaling modulates the expression of PD-L1 following docetaxel chemotherapy in prostate cancer.
    Wang Z; Zhang X; Li W; Su Q; Huang Z; Zhang X; Chen H; Mo C; Huang B; Ou W; Chen J; Zhao G; Chen L; Shao L
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34301812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition.
    Tamaki H; Harashima N; Hiraki M; Arichi N; Nishimura N; Shiina H; Naora K; Harada M
    Oncotarget; 2014 Nov; 5(22):11399-412. PubMed ID: 25333266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nimbolide inhibits androgen independent prostate cancer cells survival and proliferation by modulating multiple pro-survival signaling pathways.
    Singh PR; Priya ES; Balakrishnan S; Arunkumar R; Sharmila G; Rajalakshmi M; Arunakaran J
    Biomed Pharmacother; 2016 Dec; 84():1623-1634. PubMed ID: 27889231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting IκB Kinase β/NF-κB Signaling in Human Prostate Cancer by a Novel IκB Kinase β Inhibitor CmpdA.
    Zhang Y; Lapidus RG; Liu P; Choi EY; Adediran S; Hussain A; Wang X; Liu X; Dan HC
    Mol Cancer Ther; 2016 Jul; 15(7):1504-14. PubMed ID: 27196761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB.
    Kim SM; Lee SY; Cho JS; Son SM; Choi SS; Yun YP; Yoo HS; Yoon DY; Oh KW; Han SB; Hong JT
    Eur J Pharmacol; 2010 Apr; 631(1-3):1-9. PubMed ID: 20056115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of cysteine 179 of IkappaBalpha kinase by nimbolide leads to down-regulation of NF-kappaB-regulated cell survival and proliferative proteins and sensitization of tumor cells to chemotherapeutic agents.
    Gupta SC; Prasad S; Reuter S; Kannappan R; Yadav VR; Ravindran J; Hema PS; Chaturvedi MM; Nair M; Aggarwal BB
    J Biol Chem; 2010 Nov; 285(46):35406-17. PubMed ID: 20829362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-tomatine attenuation of in vivo growth of subcutaneous and orthotopic xenograft tumors of human prostate carcinoma PC-3 cells is accompanied by inactivation of nuclear factor-kappa B signaling.
    Lee ST; Wong PF; He H; Hooper JD; Mustafa MR
    PLoS One; 2013; 8(2):e57708. PubMed ID: 23437404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
    Shukla S; Gupta S
    Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity.
    Domingo-Domenech J; Oliva C; Rovira A; Codony-Servat J; Bosch M; Filella X; Montagut C; Tapia M; Campás C; Dang L; Rolfe M; Ross JS; Gascon P; Albanell J; Mellado B
    Clin Cancer Res; 2006 Sep; 12(18):5578-86. PubMed ID: 17000695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nimbolide, a limonoid triterpene, inhibits growth of human colorectal cancer xenografts by suppressing the proinflammatory microenvironment.
    Gupta SC; Prasad S; Sethumadhavan DR; Nair MS; Mo YY; Aggarwal BB
    Clin Cancer Res; 2013 Aug; 19(16):4465-76. PubMed ID: 23766363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic nanoparticles of Fe3O4 enhance docetaxel-induced prostate cancer cell death.
    Sato A; Itcho N; Ishiguro H; Okamoto D; Kobayashi N; Kawai K; Kasai H; Kurioka D; Uemura H; Kubota Y; Watanabe M
    Int J Nanomedicine; 2013; 8():3151-60. PubMed ID: 23990723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells.
    Ling MT; Wang X; Ouyang XS; Xu K; Tsao SW; Wong YC
    Oncogene; 2003 Jul; 22(29):4498-508. PubMed ID: 12881706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone methyltransferase NSD2/MMSET mediates constitutive NF-κB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop.
    Yang P; Guo L; Duan ZJ; Tepper CG; Xue L; Chen X; Kung HJ; Gao AC; Zou JX; Chen HW
    Mol Cell Biol; 2012 Aug; 32(15):3121-31. PubMed ID: 22645312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen receptor negatively regulates mitotic checkpoint signaling to induce docetaxel resistance in castration-resistant prostate cancer.
    Pilling A; Kim SH; Hwang C
    Prostate; 2022 Feb; 82(2):182-192. PubMed ID: 34672379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of roburic acid in combination with docetaxel on human prostate cancer cells.
    Wang X; Xuetao X; Wu M; Wu P; Sheng Z; Liu W; Ma YY; Zhao DG; Zhang K; Li D; Zheng X; Goodin S
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):542-553. PubMed ID: 34986722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein Disulfide Isomerase 4 Drives Docetaxel Resistance in Prostate Cancer.
    Qian S; Zhang S; Wu Y; Ding Y; ; Li X
    Chemotherapy; 2020; 65(5-6):125-133. PubMed ID: 33238278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal Circ-XIAP Promotes Docetaxel Resistance in Prostate Cancer by Regulating miR-1182/TPD52 Axis.
    Zhang H; Li M; Zhang J; Shen Y; Gui Q
    Drug Des Devel Ther; 2021; 15():1835-1849. PubMed ID: 33976535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.